MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202311078554 A) filed by Council Of Scientific And Industrial Research, New Delhi, on Nov. 16, 2023, for 'magnetically controlled drug delivery device.'
Inventor(s) include Ishita Matai; Vijayesh Kumar; Abhay Sachdev; Gurvinder Kaur; and Pradipta Samanta.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "Magnetically Controlled Drug Delivery Device Disclosed is a device and method for magnetic field stimulated drug release from drug loaded magnetic hydrogel. The device of the present invention comprises of integrated parallel electromagnets that can be modulated by variable current source and magnetic hydrogel. The magnetic hydrogel includes a cross-linked porous matrix of natural or synthetic hydrophilic polymer, a magnetic nanoparticle, and a model drug. The magnetic field strength on the magnetic hydrogel can be varied by altering the source current and distance between the two parallel electromagnets in the wearable device. The quantity of drug release from the drug loaded magnetic hydrogel can be controlled by externally varying magnetic field strength. Further, the invention supports a wide possibility of application scenarios for biomedical, biotechnology and pharmaceutical, and related development of drug delivery products."
Disclaimer: Curated by HT Syndication.
